Evidence map›Paper›PMID 25096814›Full record

ArticleThe Journal of general virology2014

Analysis of purified wild type and mutant adenovirus particles by SILAC based quantitative proteomics.

Ali Alqahtani, Kate Heesom, Jonathan L Bramson, David Curiel, Hideyo Ugai, David A Matthews

Abstract read
In one paragraph

Article in The Journal of general virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Advances in Mass Spectrometric Tools for Probing Neuropeptides.Annual review of analytical chemistry (Palo Alto, Calif.) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali AlqahtaniCollege of Applied Medical Sciences, Najran University, Najran 1983, Saudi Arabia.
Kate HeesomProteomics Facility, Faculty of Medical and Veterinary Sciences, University Walk, University of Bristol, Bristol BS8 1TD, UK.
Jonathan L BramsonMcMaster Immunology Research Centre, 4016 Michael DeGroote Centre for Learning & Discovery, McMaster University, Hamilton, L8S 4L8 Ontario, Canada.
David CurielBiologic Therapeutics Center, School of Medicine, Washington University in St Louis, 4511 Forest Park Medical Building, St Louis, MO 63108, USA.
Hideyo UgaiCancer Biology Division, Department of Radiation Oncology, School of Medicine, Washington University in St Louis, 4511 Forest Park Medical Building, St Louis, MO 63108, USA.
David A MatthewsSchool of Cellular and Molecular Medicine, University Walk, University of Bristol, Bristol BS8 1TD, UK.

Funding

Wellcome TrustWellcome Trust 083604
6 · The paper itself

Abstract

We used SILAC (stable isotope labelling of amino acids in cell culture) and high-throughput quantitative MS mass spectrometry to analyse the protein composition of highly purified WT wild type adenoviruses, mutant adenoviruses lacking an internal protein component (protein V) and recombinant adenoviruses of the type commonly used in gene therapy, including one virus that had been used in a clinical trial. We found that the viral protein abundance and composition were consistent across all types of virus examined except for the virus lacking protein V, which also had reduced amounts of another viral core protein, protein VII. In all the samples analysed we found no evidence of consistent packaging or contamination with cellular proteins. We believe this technique is a powerful method to analyse the protein composition of this important gene therapy vector and genetically engineered or synthetic virus-like particles. The raw data have been deposited at proteomexchange, identifer PXD001120.

Indexed as

Adenoviruses, HumanAmino AcidsCell LineHEK293 CellsHeLa CellsHumansIsotope LabelingMutationProteomicsTandem Mass SpectrometryViral ProteinsAmino AcidsViral Proteins

Identifiers

PMID25096814
PMCPMC4202269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.